Status:

RECRUITING

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

Lead Sponsor:

Fred Hutchinson Cancer Center

Collaborating Sponsors:

Andy Hill CARE Fund

Conditions:

Ovarian Carcinoma

Psychiatric Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology clinicians. Stress and burnout among gynecolo...

Detailed Description

OUTLINE: OBJECTIVE 1 DEVELOPMENT OF INTERVENTION: Clinicians review HOPE-C intervention materials and complete an interview and questionnaire on study. OBJECTIVE 2 PILOT TRIAL: Clinicians attend HOP...

Eligibility Criteria

Inclusion Criteria:

  • Age 18 years of age or older
  • English speaking
  • Able to provide informed consent
  • Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers [APPs])

Key Trial Info

Start Date :

May 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2029

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT07282158

Start Date

May 1 2026

End Date

December 31 2029

Last Update

April 8 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States, 98109

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians | DecenTrialz